OMER News and Press, Omeros Corporation From 05/11/20

Omeros (NASDAQ: OMER ): Q1 Non-GAAP EPS of -$0.41 misses by $0.07 ; GAAP EPS of -$0.53 misses by $0.19 . Revenue of $23.5M (+7.9% Y/Y) misses by $6.71M . Press Release More news on: Omeros Corporation, Earnings news and commentary, Healthcare stocks news,

– Conference Call Today at 4:30 p.m. ET – Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications target...

Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its first quarter financial results for the period ended March 31, 2020, on Monday, May 11, 2020, after the market closes. Omeros management will host a conference call and webcast that day at 4:30 p.m. Eastern Tim...

Note: For a full background on OMER, please see our Top Idea article from July 15, 2019. On July 15, 2019, we published a Top Idea article on Omeros Corporation (NASDAQ: OMER ) highlighting their lead investigational candidate narsoplimab, which we view as one of the most compelling pipe...

Omeros' ( OMER ) business plan envisions that it use revenues from OMIDRIA, its FDA-approved therapy, to finance its exciting development pipeline. The company's plan has struggled over reimbursement issues in the past, which are likely to raise their head again. This article discusses how...

Omeros Corporation (NASDAQ: OMER) today announced that the company will issue its fourth quarter and year-end 2019 financial results for the period ended December 31, 2019, on Monday, March 2, 2020, after the market closes. Omeros management will host a conference call and webcast that day at...

-- Zumwalt Also to Serve as Consultant, Bringing Extensive Capital Markets Background to Omeros -- Omeros Corporation (NASDAQ: OMER) today announced the appointment of Kurt Zumwalt, former global treasurer of Amazon.com, Inc., to Omeros’ Board of Directors. He will also serve in...

Back in the thirties we were told we must collectivize the nation because the people were so poor. Now we are told we must collectivize the nation because the people are so rich .”― William F. Buckley Jr. Today, we revisit a ' Tier 3 ' biotech stock whose stock has been un...

This article was highlighted for PRO+ subscribers, Seeking Alpha’s service for professional investors. Find out how you can get the best content on Seeking Alpha here . 2019 was difficult for short-sellers considering what ended up being a historically strong year for the...

Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year test now using the top four forensic algorithms applied to detect bankruptcy risk, earnings manipulation, and financial irregularities. This forward testing study co...